![](/img/cover-not-exists.png)
241P NAB-paclitaxel as third-line therapy after failure of gemcitabine and 5-fluorouracil (5-FU) based combinations in advanced gall bladder cancer patients
Goel, V., Talwar, V., Patnaik, N., Raina, S., Singh, S.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw582.022
Date:
December, 2016
File:
PDF, 54 KB
english, 2016